Literature DB >> 3015396

Human T-cell leukemia virus I provirus and antibodies in a captive gorilla with non-Hodgkin's lymphoma.

B I Srivastava, F Wong-Staal, J P Getchell.   

Abstract

Antibodies reactive against human T-cell leukemia virus I (HTLV-I) were detected by indirect immunofluorescence assay using MT-2 as target cells, enzyme linked immunosorbent assay screen and competition assay, and Western blot analysis in three sera (one collected in 1979) from a captive gorilla which developed diffuse histiocytic lymphoma in 1983. The sera from four other healthy gorillas housed separately were HTLV-I antibody negative. All sera were negative for HTLV-III antibodies by enzyme linked immunosorbent assay. Southern blot analysis of DNA from lymphoma tissue after digestion with BamHI and using complete HTLV-I genome probe gave one 10-kilobase fragment and a characteristic 1.05-kilobase internal fragment detected in all known HTLV-I isolates. These results indicate that the gorilla was infected with HTLV-I or a closely related simian virus several years before the development of lymphoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015396

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

Review 1.  Malignant lymphomas in Japan: epidemiological analysis of adult T-cell leukemia/lymphoma (ATL).

Authors:  K Tajima
Journal:  Cancer Metastasis Rev       Date:  1988-11       Impact factor: 9.264

2.  Isolation and characterization of a new simian T-cell leukemia virus type 1 from naturally infected celebes macaques (Macaca tonkeana): complete nucleotide sequence and phylogenetic relationship with the Australo-Melanesian human T-cell leukemia virus type 1.

Authors:  F Ibrahim; G de Thé; A Gessain
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 3.  STLV-1 as a model for studying HTLV-1 infection.

Authors:  Brice Jégado; Fatah Kashanchi; Hélène Dutartre; Renaud Mahieux
Journal:  Retrovirology       Date:  2019-12-16       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.